Kimberly C. Vendrov

812 total citations
17 papers, 609 citations indexed

About

Kimberly C. Vendrov is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Kimberly C. Vendrov has authored 17 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 7 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Kimberly C. Vendrov's work include Clostridium difficile and Clostridium perfringens research (10 papers), Gut microbiota and health (6 papers) and Microscopic Colitis (5 papers). Kimberly C. Vendrov is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (10 papers), Gut microbiota and health (6 papers) and Microscopic Colitis (5 papers). Kimberly C. Vendrov collaborates with scholars based in United States. Kimberly C. Vendrov's co-authors include Vincent B. Young, Nageswara R. Madamanchi, Jacques Robidoux, Arihiro Sumida, Aleksandr E. Vendrov, Marschall S. Runge, Alberto Smith, Craig R. Lee, Darryl C. Zeldin and Matthew L. Edin and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Journal of Lipid Research.

In The Last Decade

Kimberly C. Vendrov

17 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimberly C. Vendrov United States 13 230 168 159 139 108 17 609
Keshu Xu China 17 303 1.3× 377 2.2× 51 0.3× 69 0.5× 48 0.4× 27 768
Vuyolwethu Mxinwa South Africa 17 174 0.8× 122 0.7× 31 0.2× 40 0.3× 136 1.3× 27 591
Kunissery A. Balasubramanian India 15 187 0.8× 234 1.4× 55 0.3× 26 0.2× 87 0.8× 24 764
Anabel García‐Heredia Spain 19 175 0.8× 103 0.6× 71 0.4× 18 0.1× 78 0.7× 40 752
Mevlüt Başkol Türkiye 17 263 1.1× 291 1.7× 46 0.3× 25 0.2× 99 0.9× 50 1.0k
Caroline Pelletier France 9 231 1.0× 85 0.5× 23 0.1× 68 0.5× 224 2.1× 15 655
Tommy Pacana United States 9 202 0.9× 577 3.4× 48 0.3× 46 0.3× 127 1.2× 20 848
Kaoru Arii Japan 18 176 0.8× 111 0.7× 133 0.8× 19 0.1× 54 0.5× 40 1.1k
Yasuhiro Nishizaki Japan 14 153 0.7× 181 1.1× 22 0.1× 51 0.4× 97 0.9× 83 597
Raimón Ferré Spain 18 251 1.1× 110 0.7× 25 0.2× 142 1.0× 148 1.4× 56 983

Countries citing papers authored by Kimberly C. Vendrov

Since Specialization
Citations

This map shows the geographic impact of Kimberly C. Vendrov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly C. Vendrov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly C. Vendrov more than expected).

Fields of papers citing papers by Kimberly C. Vendrov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly C. Vendrov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly C. Vendrov. The network helps show where Kimberly C. Vendrov may publish in the future.

Co-authorship network of co-authors of Kimberly C. Vendrov

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly C. Vendrov. A scholar is included among the top collaborators of Kimberly C. Vendrov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly C. Vendrov. Kimberly C. Vendrov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Vendrov, Kimberly C., et al.. (2025). Host origin of microbiota drives functional recovery and Clostridioides difficile clearance in mice. mBio. 16(7). e0110825–e0110825. 2 indexed citations
2.
3.
Bongers, Kale S., Rishi Chanderraj, Robert J. Woods, et al.. (2022). The Gut Microbiome Modulates Body Temperature Both in Sepsis and Health. American Journal of Respiratory and Critical Care Medicine. 207(8). 1030–1041. 23 indexed citations
4.
Abernathy‐Close, Lisa, James George, Michael G. Dieterle, et al.. (2021). Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection. mBio. 12(3). e0273320–e0273320. 23 indexed citations
5.
Leslie, Jhansi L., Matthew L. Jenior, Kimberly C. Vendrov, et al.. (2021). Protection from Lethal Clostridioides difficile Infection via Intraspecies Competition for Cogerminant. mBio. 12(2). 24 indexed citations
6.
Abernathy‐Close, Lisa, Michael G. Dieterle, Kimberly C. Vendrov, et al.. (2020). Aging Dampens the Intestinal Innate Immune Response during Severe Clostridioides difficile Infection and Is Associated with Altered Cytokine Levels and Granulocyte Mobilization. Infection and Immunity. 88(6). 11 indexed citations
8.
Dieterle, Michael G., Lisa Abernathy‐Close, Kimberly C. Vendrov, et al.. (2020). Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection. mBio. 11(3). 19 indexed citations
9.
Mau, Theresa, Ingrid L. Bergin, Jason Villano, et al.. (2019). Outbreak of Murine Infection with Clostridium difficile Associated with the Administration of a Pre- and Perinatal Methyl Donor Diet. mSphere. 4(2). 2 indexed citations
10.
Leslie, Jhansi L., Kimberly C. Vendrov, Matthew L. Jenior, & Vincent B. Young. (2019). The Gut Microbiota Is Associated with Clearance of Clostridium difficile Infection Independent of Adaptive Immunity. mSphere. 4(1). 32 indexed citations
11.
12.
Wang, Nan, Kimberly C. Vendrov, Brian Simmons, et al.. (2017). Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease. Prostaglandins & Other Lipid Mediators. 134. 24–31. 19 indexed citations
13.
Wells, Michael A., Kimberly C. Vendrov, Matthew L. Edin, et al.. (2016). Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis. Prostaglandins & Other Lipid Mediators. 125. 19–29. 27 indexed citations
14.
Vendrov, Aleksandr E., Kimberly C. Vendrov, Alberto Smith, et al.. (2015). NOX4 NADPH Oxidase-Dependent Mitochondrial Oxidative Stress in Aging-Associated Cardiovascular Disease. Antioxidants and Redox Signaling. 23(18). 1389–1409. 170 indexed citations
15.
Oni‐Orisan, Akinyemi, Matthew L. Edin, Michael A. Wells, et al.. (2015). Cytochrome P450-derived epoxyeicosatrienoic acids and coronary artery disease in humans: a targeted metabolomics study. Journal of Lipid Research. 57(1). 109–119. 55 indexed citations
16.
Zha, Weibin, Matthew L. Edin, Kimberly C. Vendrov, et al.. (2014). Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity. Journal of Lipid Research. 55(10). 2124–2136. 69 indexed citations
17.
Schuck, Robert N., Weibin Zha, Matthew L. Edin, et al.. (2014). The Cytochrome P450 Epoxygenase Pathway Regulates the Hepatic Inflammatory Response in Fatty Liver Disease. PLoS ONE. 9(10). e110162–e110162. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026